Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy

Katoch, K.; Ramu, G.; Ramanathan, U.; Sengupta, U.; Sreevatsa

Indian Journal of Leprosy 59(1): 36-43

1987


ISSN/ISBN: 0254-9395
PMID: 3611859
Document Number: 294950
56 lepromatous leprosy patients with an initial average BI of 4.45 were administered once a month 600 mg of Rifampicin, 100 mg of Clofazimine on alternate days and 100 mg of Dapsone daily. None of these patients became smear negative in 2 years, and the same regimen was continued further. Two patients have become negative in 3 years and treatment has been stopped in them. The study indicates that highly bacilliferous LL/BL patients are likely to need 3 years or more of MDT for achieving bacterial negativity.

Document emailed within 1 workday
Secure & encrypted payments